4th Quarter - Report

W STRATEGIES, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Monitored Child Nutrition Reauthorization.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Monitored legislative efforts to reform the corporate tax system. P.L. 114-113: "Consolidated Appropriations Act" with respect to the Protecting Americans from Tax Hikes Act and provisions related to delay in the medical device tax and excise tax on high value health plans;James Zadroga 9/11 Health and Compensation Reauthorization as it relates to offsets impacting DMEPOS in Medicaid. S. 2045: Middle Class Health Benefits Tax Repeal Act of 2015.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2045 (114th)

Medicare/Medicaid MMM

H.R.3291: Medicare Crosswalk Hospital Code Development Act of 2015.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3291 (114th)

Health Issues HCR

H.R. 1559: Safe and Accurate Food Labeling Act of 2014. H.R. 6: 21st Century Cures Act, specifically as it relates to DMEPOS Competitive Bidding and Medicaid. Draft legislation dealing with regulation of laboratory developed tests.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th), H.R. 1559 (114th)

Budget/Appropriations BUD

P.L. 114-74: Bipartisan Budget Act of 2015.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.